RhumbLine Advisers
SRRA

RhumbLine Advisers’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

RhumbLine Advisers’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-19,058
Closed -$1.05M – 3106
2022
Q2 		$1.05M Buy
+19,058
New +$1.05M ﹤0.01% 2117